Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155223 | SCV000204909 | likely benign | not specified | 2014-08-07 | criteria provided, single submitter | clinical testing | Arg150Arg in exon 5 of MYO7A: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 7/8372 of European A merican chromosomes and 1/4076 of African American chromosomes by the NHLBI Exom e Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs121965079). |
Prevention |
RCV000155223 | SCV000303296 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Ce |
RCV000487904 | SCV000574900 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | MYO7A: BP4, BS2 |
Gene |
RCV000487904 | SCV000984196 | likely benign | not provided | 2018-04-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000487904 | SCV001104083 | benign | not provided | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001109454 | SCV001266795 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001115097 | SCV001273042 | uncertain significance | Usher syndrome type 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001115098 | SCV001273043 | uncertain significance | Autosomal dominant nonsyndromic hearing loss 11 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Genome- |
RCV001115098 | SCV002015933 | benign | Autosomal dominant nonsyndromic hearing loss 11 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001109454 | SCV002015934 | likely benign | Autosomal recessive nonsyndromic hearing loss 2 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001115097 | SCV002015935 | likely benign | Usher syndrome type 1 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001274688 | SCV001459055 | uncertain significance | Usher syndrome type 1B | 2020-04-16 | no assertion criteria provided | clinical testing |